• Discordant amyloid-β PET and CSF biomarkers and its clinical consequencesWilde, Arno de; Reimand, Juhan; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 78, 13 p. : ill https://doi.org/10.1186/s13195-019-0532-x https://www.scopus.com/sourceid/19700174935 https://www.scopus.com/record/display.uri?eid=2-s2.0-85072103935&origin=inward&txGid=bf3373ff7d55788a6c63ff3815f91f87 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=ALZHEIMERS%20RES%20THER&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000485872800001
• PET and CSF amyloid-β status are differently predicted by patient features: Information from discordant casesReimand, Juhan; Wilde, Arno de; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 100, 16 p. : ill https://doi.org/10.1186/s13195-019-0561-5 https://www.scopus.com/sourceid/19700174935 https://www.scopus.com/record/display.uri?eid=2-s2.0-85076219172&origin=inward&txGid=123d074ff9dba3bc97dc38d450293f63 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=ALZHEIMERS%20RES%20THER&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000501219100001